269 related articles for article (PubMed ID: 15280366)
41. Smac/Diablo antagonizes ubiquitin ligase activity of inhibitor of apoptosis proteins.
Creagh EM; Murphy BM; Duriez PJ; Duckett CS; Martin SJ
J Biol Chem; 2004 Jun; 279(26):26906-14. PubMed ID: 15078891
[TBL] [Abstract][Full Text] [Related]
42. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain.
Huang Y; Park YC; Rich RL; Segal D; Myszka DG; Wu H
Cell; 2001 Mar; 104(5):781-90. PubMed ID: 11257231
[TBL] [Abstract][Full Text] [Related]
43. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.
Roy N; Deveraux QL; Takahashi R; Salvesen GS; Reed JC
EMBO J; 1997 Dec; 16(23):6914-25. PubMed ID: 9384571
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
45. The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition.
Shin H; Renatus M; Eckelman BP; Nunes VA; Sampaio CA; Salvesen GS
Biochem J; 2005 Jan; 385(Pt 1):1-10. PubMed ID: 15485395
[TBL] [Abstract][Full Text] [Related]
46. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs.
Scott FL; Denault JB; Riedl SJ; Shin H; Renatus M; Salvesen GS
EMBO J; 2005 Feb; 24(3):645-55. PubMed ID: 15650747
[TBL] [Abstract][Full Text] [Related]
47. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.
Du C; Fang M; Li Y; Li L; Wang X
Cell; 2000 Jul; 102(1):33-42. PubMed ID: 10929711
[TBL] [Abstract][Full Text] [Related]
48. Structures of BIR domains from human NAIP and cIAP2.
Herman MD; Moche M; Flodin S; Welin M; Trésaugues L; Johansson I; Nilsson M; Nordlund P; Nyman T
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Nov; 65(Pt 11):1091-6. PubMed ID: 19923725
[TBL] [Abstract][Full Text] [Related]
49. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation.
Chamaillard M; Girardin SE; Viala J; Philpott DJ
Cell Microbiol; 2003 Sep; 5(9):581-92. PubMed ID: 12925128
[TBL] [Abstract][Full Text] [Related]
50. Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9.
Denault JB; Eckelman BP; Shin H; Pop C; Salvesen GS
Biochem J; 2007 Jul; 405(1):11-9. PubMed ID: 17437405
[TBL] [Abstract][Full Text] [Related]
51. Structural basis of caspase-7 inhibition by XIAP.
Chai J; Shiozaki E; Srinivasula SM; Wu Q; Datta P; Alnemri ES; Shi Y
Cell; 2001 Mar; 104(5):769-80. PubMed ID: 11257230
[TBL] [Abstract][Full Text] [Related]
52. Neuronal leucine-rich repeat protein-3 amplifies MAPK activation by epidermal growth factor through a carboxyl-terminal region containing endocytosis motifs.
Fukamachi K; Matsuoka Y; Ohno H; Hamaguchi T; Tsuda H
J Biol Chem; 2002 Nov; 277(46):43549-52. PubMed ID: 12297494
[TBL] [Abstract][Full Text] [Related]
53. The activator of apoptosis Smac-DIABLO acts as a tetramer in solution.
Mastrangelo E; Vachette P; Cossu F; Malvezzi F; Bolognesi M; Milani M
Biophys J; 2015 Feb; 108(3):714-23. PubMed ID: 25650938
[TBL] [Abstract][Full Text] [Related]
54. Livin, a novel inhibitor of apoptosis protein family member.
Kasof GM; Gomes BC
J Biol Chem; 2001 Feb; 276(5):3238-46. PubMed ID: 11024045
[TBL] [Abstract][Full Text] [Related]
55. ARTS binds to a distinct domain in XIAP-BIR3 and promotes apoptosis by a mechanism that is different from other IAP-antagonists.
Bornstein B; Gottfried Y; Edison N; Shekhtman A; Lev T; Glaser F; Larisch S
Apoptosis; 2011 Sep; 16(9):869-81. PubMed ID: 21695558
[TBL] [Abstract][Full Text] [Related]
56. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.
Vucic D; Stennicke HR; Pisabarro MT; Salvesen GS; Dixit VM
Curr Biol; 2000 Nov; 10(21):1359-66. PubMed ID: 11084335
[TBL] [Abstract][Full Text] [Related]
57. The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein.
Hegde R; Srinivasula SM; Datta P; Madesh M; Wassell R; Zhang Z; Cheong N; Nejmeh J; Fernandes-Alnemri T; Hoshino S; Alnemri ES
J Biol Chem; 2003 Oct; 278(40):38699-706. PubMed ID: 12865429
[TBL] [Abstract][Full Text] [Related]
58. Structural and biochemical basis of apoptotic activation by Smac/DIABLO.
Chai J; Du C; Wu JW; Kyin S; Wang X; Shi Y
Nature; 2000 Aug; 406(6798):855-62. PubMed ID: 10972280
[TBL] [Abstract][Full Text] [Related]
59. Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.
Sun H; Nikolovska-Coleska Z; Yang CY; Xu L; Tomita Y; Krajewski K; Roller PP; Wang S
J Med Chem; 2004 Aug; 47(17):4147-50. PubMed ID: 15293984
[TBL] [Abstract][Full Text] [Related]
60. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
